Andreia M Nunes Selected Research

SU 9516

1/2017	Commentary: SU9516 increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
1/2017	SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreia M Nunes Research Topics

Disease

4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2019 - 01/2017
3	Disease Progression 01/2019 - 01/2017
2	Facioscapulohumeral Muscular Dystrophy 01/2022 - 01/2021
2	Muscular Dystrophies (Muscular Dystrophy) 01/2019 - 09/2017
1	Muscle Weakness 01/2022
1	Muscular Diseases (Myopathy) 09/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Neoplasms (Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
3	IntegrinsIBA 01/2017 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	SU 9516IBA 01/2017 - 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Sunitinib (Sutent)FDA Link 01/2019
1	DystrophinIBA 01/2017
1	Laminin ReceptorsIBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2019 - 09/2017
1	Palliative Care (Palliative Therapy) 09/2017